InsightfulValue
← Home

Merck
Merck

-4.8%

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
πŸ“’ Press Releases

Date Press release
2025-05-29 07:00:00 Patritumab Deruxtecan Biologics License Application For Patients With Previously Treated Locally Advanced Or Metastatic Egfr-mutated Non-small Cell Lung Cancer Voluntarily Withdrawn
Basking ridge, n.j. & rahway, n.j.--(business wire)--the biologics license application (bla) seeking accelerated approval in the u.s. for daiichi sankyo (tse: 4568) and merck’s (nyse: mrk), known as msd outside of the united states and canada, patritumab deruxtecan (her3-dxd) based on the herthena-lung01 phase 2 trial for the treatment of adult patients with locally advanced or metastatic egfr-mutated non-small cell lung cancer (nsclc) previously treated with two or more systemic therapies has.
2025-05-27 13:24:00 Merck Announces Third-quarter 2025 Dividend
Rahway, n.j.--(business wire)--merck announces third-quarter 2025 dividend.
2025-05-22 17:43:00 Merck Showcases Innovation In Advanced Cancers And Rare Tumors At Asco 2025
Darmstadt, germany--(business wire)--merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 american society of clinical oncology (asco) annual meeting, may 31 to june 4 in chicago. the presentations include the phase 3 maneuver data for potentially best-in-class pimicotinib in the treatment of the rare tumor tgct, as well as data from both company- and investigator-sponsored studies highlighting the com.
2025-05-22 06:45:00 Merck To Participate In The Bernstein 41st Annual Strategic Decisions Conference
Rahway, n.j.--(business wire)--merck to participate in the bernstein 41st annual strategic decisions conference.
2025-05-21 08:15:00 Merck Presents Positive Phase 2 Data For Enpatoran Demonstrating Reduction In Disease Activity In Patients With Cutaneous Lupus Erythematosus (cle) And Systemic Lupus Erythematosus (sle) With Active Lupus Rash
Darmstadt, germany--(business wire)--not intended for uk-, us- or canada-based media merck, a leading science and technology company, today announced positive data on enpatoran, an investigational, oral, novel tlr7/8 inhibitor, demonstrating clinically meaningful reduction in disease activity in patients with cutaneous lupus erythematosus (cle) and systemic lupus erythematosus (sle) with active lupus rash. the findings are from cohort a of the phase 2 willow study (nct05162586). results will be.
2025-05-16 06:45:00 TWVyY2sgVG 8gUHJlc2Vu dCBOZXcgQ2 xpbmljYWwg QW5kIE91dG NvbWVzIFJl c2VhcmNoIE RhdGEgQXQg VGhlIEFtZX JpY2FuIFRo b3JhY2ljIF NvY2lldHni gJlzIChhdH MpIDIwMjUg SW50ZXJuYX Rpb25hbCBD b25mZXJlbm NlIERlbW9u c3RyYXRpbm cgQ29tbWl0 bWVudCBUby BBZHZhbmNp bmcgUmVzZW FyY2ggSW4g UHVsbW9uYX J5IEFydGVy aWFsIEh5cG VydGVuc2lv bg==
UmFod2F5LC BuLmouLS0o YnVzaW5lc3 Mgd2lyZSkt LW1lcmNrIC hueXNlOiBt cmspLCBrbm 93biBhcyBt c2Qgb3V0c2 lkZSBvZiB0 aGUgdW5pdG VkIHN0YXRl cyBhbmQgY2 FuYWRhLCB0 b2RheSBhbm 5vdW5jZWQg bmV3IGNsaW 5pY2FsIGFu ZCBvdXRjb2 1lcyByZXNl YXJjaCBkYX RhIG9uIHB1 bG1vbmFyeS BhcnRlcmlh bCBoeXBlcn RlbnNpb24g KHBhaCkgdG 8gYmUgcHJl c2VudGVkIG F0IHRoZSBh bWVyaWNhbi B0aG9yYWNp YyBzb2NpZX R54oCZcyAo YXRzKSAyMD I1IGludGVy bmF0aW9uYW wgY29uZmVy ZW5jZSBpbi BzYW4gZnJh bmNpc2NvIG Zyb20gbWF5 IDE2LTIxLi BkYXRhIGZy b20gbmluZS BwcmVzZW50 YXRpb25zIG RlbW9uc3Ry YXRlIG1lcm Nr4oCZcyBj b21taXRtZW 50IHRvIGFk dmFuY2luZy ByZXNlYXJj aCBmb3IgcG F0aWVudHMg d2l0aCB0aG lzIGRpc2Vh c2UuIG1lcm NrIHdpbGwg cHJlc2VudC Bwb29sZWQg ZGF0YSBmcm 9tIHBhcnRp Y2lwYW50cy B3aG8gaGF2 ZSBjb21wbG Uu
2025-05-15 06:45:00 TWVyY2sgQW 5ub3VuY2Vz IFBoYXNlID MgS2V5bm90 ZS1iOTYgVH JpYWwgTWV0 IFByaW1hcn kgRW5kcG9p bnQgT2YgUH JvZ3Jlc3Np b24tZnJlZS BTdXJ2aXZh bCAocGZzKS BJbiBQYXRp ZW50cyBXaX RoIFBsYXRp bnVtLXJlc2 lzdGFudCBS ZWN1cnJlbn QgT3Zhcmlh biBDYW5jZX IgV2hvc2Ug VHVtb3JzIE V4cHJlc3Nl ZCBQZC1sMS BBbmQgSW4g QWxsIENvbW Vycw==
UmFod2F5LC BuLmouLS0o YnVzaW5lc3 Mgd2lyZSkt LS0tICRtcm sgI21yay0t bWVyY2sgYW 5ub3VuY2Vz IHBvc2l0aX ZlIHRvcGxp bmUgcmVzdW x0cyBvZiBw aGFzZSAzIG tleW5vdGUt Yjk2IHRyaW FsIGluIHBh dGllbnRzIH dpdGggcGxh dGludW0tcm VzaXN0YW50 IHJlY3Vycm VudCBvdmFy aWFuIGNhbm Nlci4=
2025-05-14 17:15:00 RmRhIEFwcH JvdmVzIE1l cmNr4oCZcy BXZWxpcmVn wq4gKGJlbH p1dGlmYW4p IEZvciBUaG UgVHJlYXRt ZW50IE9mIE FkdWx0cyBB bmQgUGVkaW F0cmljIFBh dGllbnRzID EyIFllYXJz IEFuZCBPbG RlciBXaXRo IExvY2FsbH kgQWR2YW5j ZWQsIFVucm VzZWN0YWJs ZSwgT3IgTW V0YXN0YXRp YyBQaGVvY2 hyb21vY3l0 b21hIE9yIF BhcmFnYW5n bGlvbWEgKH BwZ2wp
UmFod2F5LC BuLmouLS0o YnVzaW5lc3 Mgd2lyZSkt LS0tICRtcm sgI21yay0t d2VsaXJlZy BwcGdsIGZk YSBhcHByb3 ZhbCBuZXdz IHJlbGVhc2 Uu
2025-05-13 06:45:00 UmVzZWFyY2 ggT24gTm92 ZWwgVHJlYX RtZW50IEFw cHJvYWNoZX MgQW5kIFNj aWVudGlmaW MgQWR2YW5j ZXMgRnJvbS BNZXJja+KA mXMgQnJvYW QgQW5kIERp ZmZlcmVudG lhdGVkIE9u Y29sb2d5IF BvcnRmb2xp byBBbmQgUG lwZWxpbmUg VG8gQmUgUH Jlc2VudGVk IEF0IEFzY2 8gMjAyNQ==
UmFod2F5LC BuLmouLS0o YnVzaW5lc3 Mgd2lyZSkt LS0tICRtcm sgI21yay0t bWVyY2sgKG 55c2U6IG1y ayksIGtub3 duIGFzIG1z ZCBvdXRzaW RlIG9mIHRo ZSB1bml0ZW Qgc3RhdGVz IGFuZCBjYW 5hZGEsIHRv ZGF5IGFubm 91bmNlZCBu ZXcgcmVzZW FyY2ggYWNy b3NzIG1vcm UgdGhhbiAy NSB0eXBlcy BvZiBjYW5j ZXIgYW5kIG 11bHRpcGxl IHRyZWF0bW VudCBzZXR0 aW5ncyBmcm 9tIHRoZSBj b21wYW554o CZcyBicm9h ZCBhbmQgZG lmZmVyZW50 aWF0ZWQgcG 9ydGZvbGlv IGFuZCBwaX BlbGluZSB3 aWxsIGJlIH Nob3djYXNl ZCBhdCB0aG UgYW1lcmlj YW4gc29jaW V0eSBvZiBj bGluaWNhbC BvbmNvbG9n eSAoYXNjby kgYW5udWFs IG1lZXRpbm cgKG1heSAz MOKAk2p1bm UgMykuIGRh dGEgaGlnaG xpZ2h0IG1l cmNr4oCZcy Bjb21taXRt ZW50IHRvIH JhcGlkbHkg YWR2YW5jZS ByZXNlYXJj aCBhY3Jvc3 MgbXVsdGlw bGUgdHVtb3 IgdHlwZXMg YW5kIGNvbn RpbnVlIHRv IGJ1aWxkIG 9uIGl0cyBw b3J0Zm9saW 8u
2025-05-12 01:00:00 SmVpdG8gQ2 FwaXRhbCBT dHJlbmd0aG VucyBMZWFk ZXJzaGlwIE ZvciBOZXh0 IENoYXB0ZX IgT2YgR3Jv d3RoOiBNZW hkaSBBaW5v dWNoZSBQcm 9tb3RlZCBU byBQYXJ0bm VyLCBKdWxp ZW4gRWxyaW MgVG8gU2Vu aW9yIFByaW 5jaXBhbA==
UGFyaXMswq AgbWF5IDEy ICwgMjAyNS AtIGplaXRv IGNhcGl0YW wgKOKAnGpl aXRv4oCdKS wgYSBnbG9i YWwgbGVhZG luZyBpbmRl cGVuZGVudC Bwcml2YXRl IGVxdWl0eS BmdW5kIGRl ZGljYXRlZC B0byBiaW9w aGFybWEsIG lzIHBsZWFz ZWQgdG8gYW 5ub3VuY2Ug dGhlIHByb2 1vdGlvbiBv ZiBtZWhkaS BhaW5vdWNo ZSB0byBwYX J0bmVyIGFu ZCBqdWxpZW 4gZWxyaWMg dG8gc2VuaW 9yIHByaW5j aXBhbC4=
2025-05-08 06:45:00 TWVyY2sgQW 5pbWFsIEhl YWx0aCBBbm QgU3RhdGUg T2YgS2Fuc2 FzIEFubm91 bmNlICQ4OT UgTWlsbGlv biBJbnZlc3 RtZW50IElu IE1hbnVmYW N0dXJpbmcg QW5kIFJlc2 VhcmNoICYg RGV2ZWxvcG 1lbnQgRmFj aWxpdGllcy BJbiBEZSBT b3Rv
UmFod2F5LC BuLmouLS0o YnVzaW5lc3 Mgd2lyZSkt LW1lcmNrIG FuaW1hbCBo ZWFsdGgsIG tub3duIGFz IG1zZCBhbm ltYWwgaGVh bHRoIG91dH NpZGUgb2Yg dGhlIHVuaX RlZCBzdGF0 ZXMgYW5kIG NhbmFkYSwg YSBkaXZpc2 lvbiBvZiBt ZXJjayAmIG NvLiwgaW5j LiwgcmFod2 F5LCBuLmou LCB1c2EgKG 55c2U6IG1y ayksIGFuZC BrYW5zYXMg Z292ZXJub3 IgbGF1cmEg a2VsbHkgam 9pbnRseSBh bm5vdW5jZW QgdG9kYXkg dGhlICQ4OT UgbWlsbGlv biBleHBhbn Npb24gb2Yg bWVyY2sgYW 5pbWFsIGhl YWx0aOKAmX MgbWFudWZh Y3R1cmluZy BmYWNpbGl0 eSBpbiBkZS Bzb3RvLCBr YW5zYXMuIH RoZSAkODk1 IG1pbGxpb2 4gY2FwaXRh bCBleHBhbn Npb24gd2ls bCBiZSBjb2 5zdHJ1Y3Rl ZCBvbiBhbi BleGlzdGlu ZyBtZXJjay 1vd25lZCBw cm9wZXJ0eS B0aGF0IGlz IHRoZSBzaX RlIG9mIGl0 cyBiaW9sb2 dpY3MgZmFj aWxpdHkgaW 4gZGUgc290 bywga2Fuc2 FzLiBpdCBp bmMu
2025-05-07 06:45:00 TWVyY2sgVG 8gUGFydGlj aXBhdGUgSW 4gVGhlIEJh bmsgT2YgQW 1lcmljYSAy MDI1IEdsb2 JhbCBIZWFs dGhjYXJlIE NvbmZlcmVu Y2U=
UmFod2F5LC BuLmouLS0o YnVzaW5lc3 Mgd2lyZSkt LW1lcmNrIH RvIHBhcnRp Y2lwYXRlIG luIHRoZSBi YW5rIG9mIG FtZXJpY2Eg MjAyNSBnbG 9iYWwgaGVh bHRoY2FyZS Bjb25mZXJl bmNlLg==
2025-04-29 06:45:00 TWVyY2sgQn JlYWtzIEdy b3VuZCBPbi BOZXcgJDEg QmlsbGlvbi BCaW9sb2dp Y3MgQ2VudG VyIE9mIEV4 Y2VsbGVuY2 UgSW4gV2ls bWluZ3Rvbi wgRGVsYXdh cmU=
UmFod2F5LC BuLmouLS0o YnVzaW5lc3 Mgd2lyZSkt LW1lcmNrIG JyZWFrcyBn cm91bmQgb2 4gbmV3ICQx IGJpbGxpb2 4gYmlvbG9n aWNzIGNlbn RlciBvZiBl eGNlbGxlbm NlIGluIHdp bG1pbmd0b2 4sIGRlbGF3 YXJlLg==
2025-04-28 02:13:00 TWVyY2sgS2 dhYSwgRGFy bXN0YWR0LC BHZXJtYW55 IFRvIEFjcX VpcmUgU3By aW5nd29ya3 MgVGhlcmFw ZXV0aWNzIF RvIEFjY2Vs ZXJhdGUgU3 VzdGFpbmFi bGUgR3Jvd3 RoIE9mIEhl YWx0aGNhcm UgQnVzaW5l c3M=
4oCTIHB1cm NoYXNlIHBy aWNlIG9mIC Q0NyBwZXIg c2hhcmUgaW 4gY2FzaCBy ZXByZXNlbn RzIGFuIGVx dWl0eSB2YW x1ZSBvZiBh cHByb3hpbW F0ZWx5ICQz LjkgYmlsbG lvbiwgb3Ig YW4gZW50ZX JwcmlzZSB2 YWx1ZSBvZi AkMy40IGJp bGxpb24gKO KCrDMuMCBi aWxsaW9uKS DigJMg4oCT IHBsYW5uZW QgYWNxdWlz aXRpb24gd2 lsbCBpbW1l ZGlhdGVseS BhZGQgcmV2 ZW51ZSBhbm QgYWNjZWxl cmF0ZSBtaW QtIHRvIGxv bmctdGVybS Bncm93dGgg Zm9yIG1lcm NrIGtnYWEs IGRhcm1zdG FkdCwgZ2Vy bWFueeKAmX MgaGVhbHRo Y2FyZSBidX NpbmVzcyDi gJMg4oCTIH NwcmluZ3dv cmtzIHRoZX JhcGV1dGlj cyBpcyBhIH Uucy4gYmlv cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B3aXRoIGEg Zmlyc3QtaW 4tY2xhc3Ms IHN5c3RlbW ljIHN0YW5k YXJkLW9mLW NhcmUgdGhl cmFweSBpbi BhZHVsdHMg d2l0aCBkZX Ntb2lkIHR1 bW9ycyBhbm QgdGhlIGZp cnN0IGFuZC Bvbmx5IGFw cHJvdmVkIH RoZXJhcHkg Zm9yIGFkdW x0cyBhbmQg Y2hpbGRyZW 4gd2l0aCBu ZXVyb2ZpYn JvbWF0b3Np cyB0eXBlID EtYXNzb2Np YXRlZCBwbG V4aWZvcm0g bmV1cm9maW Jyb21hcyDi gJMg4oCTIH BsYW5uZWQg YWNxdWlzaX Rpb24gd2ls bCBzdHJlbm d0aGVuIHRo ZSBwcmVzZW 5jZSBvZiBt ZXJjayBrZ2 FhLCBkYXJt c3RhZHQsIG dlcm1hbnni gJlzIGhlYW x0aGNhcmUg YnVzaW5lc3 MgaW4gdGhl IHVuaXRlZC BzdGF0ZXMg YW5kIGV4cG FuZCByZWFj aCBvZiBzcH Jpbmd3b3Jr c+KAmSB0aG VyYXBldXRp YyBpbm5vdm F0aW9ucyB0 byBtb3JlIH BhdGllbnRz IHdpdGggcm FyZSB0dW1v cnMgd29ybG R3aWRlIOKA kyBzdGFtZm 9yZCwgY29u bi4sIGFwcm lsIDI4LCAy MDI1IChnbG 9iZSBuZXdz d2lyZSkgLS 0gbWVyY2sg a2dhYSwgZG FybXN0YWR0 LCBnZXJtYW 55IChkYXg6 IG1yayksIG EgbGVhZGlu ZyBzY2llbm NlIGFuZCB0 ZWNobm9sb2 d5IGNvbXBh bnksIGFuZC BzcHJpbmd3 b3JrcyB0aG VyYXBldXRp Y3MsIGluYy 4gKG5hc2Rh cTogc3d0eC ksIGEgY29t bWVyY2lhbC 1zdGFnZSBi aW9waGFybW FjZXV0aWNh bCBjb21wYW 55IGZvY3Vz ZWQgb24gc2 V2ZXJlIHJh cmUgZGlzZW FzZXMgYW5k IGNhbmNlci wgdG9kYXkg YW5ub3VuY2 VkIHRoZSBj b21wYW5pZX MgaGF2ZSBl bnRlcmVkIG ludG8gYSBk ZWZpbml0aX ZlIGFncmVl bWVudCBmb3 IgbWVyY2sg a2dhYSwgZG FybXN0YWR0 LCBnZXJtYW 55IHRvIGFj cXVpcmUgc3 ByaW5nd29y a3Mu
2025-04-28 02:11:00 TWVyY2sgS2 dhYSwgRGFy bXN0YWR0LC BHZXJtYW55 LCBUbyBBY3 F1aXJlIFVz IEJpb3BoYX JtYSBDb21w YW55IFNwcm luZ3dvcmtz IFRoZXJhcG V1dGljcyBU byBBY2NlbG VyYXRlIFN1 c3RhaW5hYm xlIEdyb3d0 aCBPZiBIZW FsdGhjYXJl IEJ1c2luZX Nz
RGFybXN0YW R0LCBnZXJt YW55LS0oYn VzaW5lc3Mg d2lyZSktLW 1lcmNrIGtn YWEsIGRhcm 1zdGFkdCwg Z2VybWFueS AoZGF4OiBt cmspLCBhIG xlYWRpbmcg c2NpZW5jZS BhbmQgdGVj aG5vbG9neS Bjb21wYW55 LCBhbmQgc3 ByaW5nd29y a3MgdGhlcm FwZXV0aWNz LCBpbmMuIC huYXNkYXE6 IHN3dHgpLC BhIHN0YW1m b3JkLCBjb2 5uZWN0aWN1 dC1iYXNlZC Bjb21tZXJj aWFsLXN0YW dlIGJpb3Bo YXJtYWNldX RpY2FsIGNv bXBhbnkgZm 9jdXNlZCBv biBzZXZlcm UgcmFyZSBk aXNlYXNlcy BhbmQgY2Fu Y2VyLCB0b2 RheSBhbm5v dW5jZWQgdG hlIGNvbXBh bmllcyBoYX ZlIGVudGVy ZWQgaW50by BhIGRlZmlu aXRpdmUgYW dyZWVtZW50 IGZvciBtZX JjayBrZ2Fh LCBkYXJtc3 RhZHQsIGdl cm1hbnksIH RvIGFjcXVp cmUgc3ByaW 5nd29ya3Mu IHRoZSBwdX JjaGFzZSBw cmljZSBvZi AkNDcgcGVy IHNoYXJlIG luIGNhc2gg cmVwcmVzZW 50cyBhbiBl cXVpdHkgdm FsdWUgb2Yg YXBwci4=
Merck

πŸ“° Browse additional press releases for Merck!

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal